Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/13/2003US20030049249 Therapy, prevention prion infections; using monoclonal antibodies encapsulated as hybridomas
03/13/2003US20030049248 Netrins
03/13/2003US20030049246 Prevent cell differentiation of nerve cells
03/13/2003US20030049245 Methods for sterilizing preparations of digestive enzymes
03/13/2003US20030049244 Method of utilizing neurotrophins to manipulate reproductive capacity
03/13/2003US20030049239 Antitumor agents, anticancer agent
03/13/2003US20030049237 Isolated nucleic acids; prevent binding of antigens; peanut allergies
03/13/2003US20030049232 Administering mixture of red blood cells and hemoglobin solution
03/13/2003US20030049227 Antitumor, anticarcinogenic agents; using fusion protein
03/13/2003US20030049203 Targeted nucleic acid constructs and uses related thereto
03/13/2003DE20201549U1 New Trojan proteosome inhibitor, useful for treating e.g. viral infections and tumors, is a fusion of inhibitor, released selectively in target cells, and Trojan peptide
03/13/2003DE20121564U1 Composition useful for treating respiratory disease, comprises a peptide that activates guanylate cyclase C, and is delivered to the apical membrane through the respiratory tract
03/13/2003CA2471735A1 Desensitizers
03/13/2003CA2459937A1 Ncam binding compounds
03/13/2003CA2459822A1 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
03/13/2003CA2459796A1 Homing peptides
03/13/2003CA2459728A1 Late gestation lung genes, fragments and uses thereof
03/13/2003CA2459517A1 Human schizophrenia gene
03/13/2003CA2459413A1 Methods for sterilizing preparations containing albumin
03/13/2003CA2459161A1 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/13/2003CA2459138A1 Modified human growth hormone
03/13/2003CA2459136A1 A caspase-8 binding protein, its preparation and use
03/13/2003CA2459077A1 Diagnosis of carcinomas
03/13/2003CA2459015A1 Use of leptin for infant with low birth weight for prevention of obesity
03/13/2003CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003CA2458915A1 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer
03/13/2003CA2458883A1 Methods of treating mycocardial event related conditions with thymosin beta 4
03/13/2003CA2458820A1 Agent for suppression of hepatitis b virus replication
03/13/2003CA2458799A1 Treatment for central nervous system disorders
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2458682A1 Nanoparticles comprising biologically active tnf which is immobilised on the same
03/13/2003CA2458677A1 Methods and compositions for treating inflammatory disorders
03/13/2003CA2458670A1 Bv8 nucleic acids and polypeptides with mitogenic activity
03/13/2003CA2458555A1 Use of c2-substituted indane-1-one systems for producing medicaments for the prophylaxis or treatment of obesity
03/13/2003CA2458553A1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity
03/13/2003CA2458552A1 Use of derivatives of c2-substituted indan-1-ol systems for producing medicaments for the prophylaxis or the treatment of obesity
03/13/2003CA2457520A1 Modified transferrin fusion proteins
03/13/2003CA2457429A1 Modified factor ix
03/13/2003CA2456904A1 Aerosolized decongestants for the treatment of sinusitis
03/13/2003CA2452044A1 Pre-mixes of glp-1 and basal insulin
03/13/2003CA2361483A1 Agent
03/12/2003EP1291429A1 Novel enzyme gene and its expression product
03/12/2003EP1291423A1 Polyfunctional base sequence and artificial gene containing the same
03/12/2003EP1291422A2 Human nucleic acid from ovarian tumor tissue
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291358A1 Feline hepatocyte growth factor
03/12/2003EP1291341A1 Compounds exhibiting thrombopoietin-like activities
03/12/2003EP1291022A1 Methods of using lanreotide, a somatostatin analogue
03/12/2003EP1291021A2 Pharmaceutical formulations for thyroid hormones
03/12/2003EP1290451A2 Diagnosis of alzheimer's disease using ldl receptor protein-1
03/12/2003EP1290449A1 Use of the g protein coupled receptor gpr3 to identify apetite control agents
03/12/2003EP1290230A2 Hepatitis c virus conjugates
03/12/2003EP1290227A1 Compositions, kits, and methods for identification and modulation of type i diabetes
03/12/2003EP1290217A2 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
03/12/2003EP1290216A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells
03/12/2003EP1290205A2 Duplexed parvovirus vectors
03/12/2003EP1290204A1 Antisense modulation of c/ebp alpha expression
03/12/2003EP1290201A2 Recombinant subunit proteins from porcine parvovirus produced in plants
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290192A2 Regulation of human plc delta-1
03/12/2003EP1290190A2 33167, a novel human hydrolase and uses therefor
03/12/2003EP1290189A2 Nucleic acid coding for a bonding site of a protein kinase of the mitogenic signalling cascade of a glycolysis-catalysing enzyme
03/12/2003EP1290188A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290185A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290183A2 2246, protein kinase molecules and uses therefor
03/12/2003EP1290182A1 Sphingosine kinase and uses thereof
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290175A1 Scramblase 2
03/12/2003EP1290174A2 G-protein coupled receptor org3.
03/12/2003EP1290172A2 Regulation of human isotocin-like g protein-coupled receptor
03/12/2003EP1290170A2 Binding agents: chimeric ligand/receptor proteins
03/12/2003EP1290169A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
03/12/2003EP1290168A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/12/2003EP1290167A1 Human kcnq5 potassium channel, methods and compositions thereof
03/12/2003EP1290166A1 Mutation in the beta 2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
03/12/2003EP1290165A2 Heteromultimeric ion channel receptor and uses thereof
03/12/2003EP1290164A2 Human twik molecules and uses thereof
03/12/2003EP1290163A2 Regulation of human serotonin-like g protein-coupled receptor
03/12/2003EP1290162A2 Induction of apoptosis and cell growth inhibition by protein 4.33
03/12/2003EP1290159A2 33166, a human hydrolase-like molecule and uses thereof
03/12/2003EP1290154A2 The identification and use of effectors and allosteric molecules for the alteration of gene expression
03/12/2003EP1290153A2 Molecular delivery vehicle for delivery of selected compounds to targets
03/12/2003EP1290148A2 AMINOACYL tRNA SYNTHETASES
03/12/2003EP1290140A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof
03/12/2003EP1290137A2 Virulence genes, proteins, and their use
03/12/2003EP1290033A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
03/12/2003EP1290030A2 Regulation of human lgr4-like g protein-coupled receptor
03/12/2003EP1290029A2 Compositions comprising net-4 modulators and their use for treating neoplastic disease
03/12/2003EP1290028A2 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF
03/12/2003EP1290027A2 Immunoadhesin for the prevention of rhinovirus infection
03/12/2003EP1290026A2 Human sez6 nucleic acids and polypeptides
03/12/2003EP1290025A2 REGULATION OF HUMAN GluR5-LIKE RECEPTOR
03/12/2003EP1290024A1 Glucose dependent release of insulin from glucose sensing insulin derivatives
03/12/2003EP1290023A2 Nuclear factor kb inducing factor
03/12/2003EP1290021A2 Polynucleotide sequence encoding a putative cell adhesion molecule
03/12/2003EP1290019A2 Use of coiled-coil structural scaffold to generate structure-specific peptides
03/12/2003EP1290017A2 Compositions and methods for delivery of a molecule into a cell
03/12/2003EP1290015A2 Epididymis-specific proteins with fibronectin type ii modules
03/12/2003EP1290013A2 Apo-ai/aii peptide derivatives
1 ... 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 ... 3163